Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology
基于一流的生物相容性冷冻保存技术的皮肤库和移植创新
基本信息
- 批准号:10618957
- 负责人:
- 金额:$ 73.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-06 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AmericanArtificial IntelligenceAttributes of ChemicalsAutologous TransplantationAwardBandageBig DataBiological AssayBirthCellsChemicalsClinicalCollaborationsCollagenContractsCoupledCryopreservationCryopreserved TissueDNA Sequence AlterationData SetDevicesDimethyl SulfoxideDomestic PigElectronsEnzyme-Linked Immunosorbent AssayEvaluationFamily suidaeFeedbackFoundationsFutureGlycerolGoalsGood Manufacturing ProcessGrowth FactorHealthHealthcare IndustryHistologyHumanImmunogeneticsIn Situ Nick-End LabelingIn VitroIndustrializationIndustryKnock-outLettersMarketingMedicineMethodsMicroscopicMissouriOrgan ProcurementsOsmosisOutcomeProceduresProcessProductionProtocols documentationQualifyingResearchResearch ContractsResourcesSafetySecureSkinSkin TransplantationSkin graftSmall Business Innovation Research GrantStainsStandardizationTechnologyTestingTissue BanksTissue DonorsTissue ProcurementsTissue TransplantationTissue ViabilityToxic effectTrademarkTransplantationUnited States National Institutes of HealthUniversitiesWorkXenograft procedurebiobankbiomaterial compatibilityclinical carecommercial prototypecommercializationefficacy evaluationevaluation/testingexperiencehealingimprovedin vivoin vivo Modelin vivo evaluationinnovationinventionmanufacturing organizationmedical schoolsnoveloperationpreservationpreventsmall molecule
项目摘要
SUMMARY
Previous support from NIH SBIR and Coulter Foundation awards allowed the CryoCrate team to develop a first-
in-class biocompatible cryopreservation medium product, trademarked as OdinSol®, that will provide efficient
options for biobanking practices associated with storage of skin grafts from donors or xenotransplants.
The OdinSol® technology removes the need for any toxic cell permeating cryoprotectant used in all existing
tissue cryopreservation methods, considerably simplifies associated operations, and more importantly, secures
the outcome of long-term storage in regular -80oC deep freezers by preventing gradual cell loss.
Based on our former experience in FDA 510(k) submission, in this project, we organized the collaboration with
our regulatory consultant (Cardinal Health), contract manufacturing organizations (Bryllan), contract research
organization (WuXi AppTec), academic collaborator (University of Missouri Department of Medicine and National
Swine Research and Research Center), to achieve the following milestones:
I. The production of OdinSol® meets GMP qualifications and biocompatibility assessment shows
compliance with FDA guidance for 510(k) submission as a storage device for transplantable tissues;
II. The in vitro and in vivo evaluation of safety and efficacy demonstrates the OdinSol® technology to be
superior to existing cryopreservation protocols with respect to preserving viability and function of skin
grafts;
III. Based on those qualifications, we will complete of the 510(k) submission and finalize of the production
line based on further FDA feedback before the end of the project period.
We expect future clinical use of the OdinSol® technology within three years after the FDA clearance, providing
the skin banking and xenotransplantation industry with a highly efficient biocompatible cryostorage platform.
总结
先前来自NIH SBIR和库尔特基金会的支持使CryoCrate团队能够开发出第一个-
商标为OdinSol®的同类生物相容性冷冻保存介质产品,其将提供有效的
与供体皮肤移植物或异种移植物的储存相关的生物库实践的选择。
OdinSol®技术消除了所有现有冷冻设备中使用的任何有毒细胞渗透冷冻保护剂的需要。
组织冷冻保存方法大大简化了相关操作,更重要的是,
通过防止细胞逐渐损失,在常规-80 ° C深冻箱中长期储存的结果。
根据我们之前在FDA 510(k)提交方面的经验,在本项目中,我们组织了与
我们的监管顾问(Cardinal Health)、合同生产组织(Bryllan)、合同研究
组织(WuXi AppTec),学术合作者(密苏里州大学医学部和国家
猪研究和研究中心),以实现以下里程碑:
I. OdinSol®的生产符合GMP资格和生物相容性评估表明
符合FDA关于作为可移植组织储存器械提交510(k)的指南;
二.安全性和有效性的体外和体内评价证明OdinSol®技术是
在保存皮肤的活力和功能方面上级现有的低温保存方案
移植物;
三.根据这些资格,我们将完成510(k)提交并完成生产
在项目期结束前,根据林业发展局的进一步反馈,
我们预计OdinSol®技术将在FDA批准后三年内投入临床使用,
皮肤银行和异种移植行业的高效生物相容性冷冻储存平台。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xu Han其他文献
Xu Han的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xu Han', 18)}}的其他基金
Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products
基于 T 细胞和 NK 细胞及其 CAR 工程产品的一流生物相容性冷冻保存技术的细胞过继免疫疗法生物库创新
- 批准号:
10611789 - 财政年份:2022
- 资助金额:
$ 73.63万 - 项目类别:
Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products
基于 T 细胞和 NK 细胞及其 CAR 工程产品的一流生物相容性冷冻保存技术的细胞过继免疫疗法生物库创新
- 批准号:
10705271 - 财政年份:2022
- 资助金额:
$ 73.63万 - 项目类别:
Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback
根据 FDA 反馈,对一流的角膜冷冻保存试剂盒进行后期临床前开发和 cGMP 生产
- 批准号:
10326323 - 财政年份:2021
- 资助金额:
$ 73.63万 - 项目类别:
A Novel Cryopreservation Technology for Large Skin Grafts to Facilitate Tissue Banking and Allograft Transplantations
一种用于大型皮肤移植物的新型冷冻保存技术,以促进组织库和同种异体移植
- 批准号:
10011745 - 财政年份:2020
- 资助金额:
$ 73.63万 - 项目类别:
An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues
用于细胞和组织玻璃化和冷冻保存的超快速冷却装置
- 批准号:
10221208 - 财政年份:2015
- 资助金额:
$ 73.63万 - 项目类别:
An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues
用于细胞和组织玻璃化和冷冻保存的超快速冷却装置
- 批准号:
10006333 - 财政年份:2015
- 资助金额:
$ 73.63万 - 项目类别:
An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues
用于细胞和组织玻璃化和冷冻保存的超快速冷却装置
- 批准号:
8834867 - 财政年份:2015
- 资助金额:
$ 73.63万 - 项目类别:
相似海外基金
I-Corps: Translation Potential of a Secure Data Platform Empowering Artificial Intelligence Assisted Digital Pathology
I-Corps:安全数据平台的翻译潜力,赋能人工智能辅助数字病理学
- 批准号:
2409130 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Standard Grant
Planning: Artificial Intelligence Assisted High-Performance Parallel Computing for Power System Optimization
规划:人工智能辅助高性能并行计算电力系统优化
- 批准号:
2414141 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Standard Grant
REU Site: CyberAI: Cybersecurity Solutions Leveraging Artificial Intelligence for Smart Systems
REU 网站:CyberAI:利用人工智能实现智能系统的网络安全解决方案
- 批准号:
2349104 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Standard Grant
EAGER: Artificial Intelligence to Understand Engineering Cultural Norms
EAGER:人工智能理解工程文化规范
- 批准号:
2342384 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Standard Grant
Reversible Computing and Reservoir Computing with Magnetic Skyrmions for Energy-Efficient Boolean Logic and Artificial Intelligence Hardware
用于节能布尔逻辑和人工智能硬件的磁斯格明子可逆计算和储层计算
- 批准号:
2343607 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Standard Grant
Artificial intelligence in education: Democratising policy
教育中的人工智能:政策民主化
- 批准号:
DP240100602 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Discovery Projects
Reassessing the Appropriateness of currently-available Data-set Protection Levers in the era of Artificial Intelligence
重新评估人工智能时代现有数据集保护手段的适用性
- 批准号:
23K22068 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
TRUST2 - Improving TRUST in artificial intelligence and machine learning for critical building management
TRUST2 - 提高关键建筑管理的人工智能和机器学习的信任度
- 批准号:
10093095 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Collaborative R&D
QUANTUM-TOX - Revolutionizing Computational Toxicology with Electronic Structure Descriptors and Artificial Intelligence
QUANTUM-TOX - 利用电子结构描述符和人工智能彻底改变计算毒理学
- 批准号:
10106704 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
EU-Funded
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
- 批准号:
MR/Y009657/1 - 财政年份:2024
- 资助金额:
$ 73.63万 - 项目类别:
Fellowship